What is more, the external validation of GSE14520 used microarray‐based data generated from 219 fresh HCC tissues also revealed that patients with low COMMD10 level showed shorter OS (p = 0.048, Figure S8), which further supports the prediction values of COMMD10 for HCC patients. This evidence concerns the gene COMMD10 and hepatocellular carcinoma.